Cosentyx is a biologic drug that is used to treat certain autoimmune diseases such as psoriasis, psoriatic arthritis, and ankylosing spondylitis. It works by blocking a specific protein in the body that causes inflammation. According to Drug Patent Watch [1], the patent for Cosentyx will expire in 2034, which means it is a relatively new drug that has not been on the market for very long.

While there is no specific information about whether or not Cosentyx is recommended for people with similar symptoms, the drug's website [2] does provide some information about its use during the COVID-19 pandemic. The website advises patients to continue taking their medication as prescribed and to talk to their healthcare provider if they have any concerns. The website also states that there is no evidence to suggest that Cosentyx increases the risk of getting COVID-19 or having a more severe case of the disease.

A Medical News Today article [3] states that Cosentyx has been shown to be effective in treating psoriasis, psoriatic arthritis, and ankylosing spondylitis. The article notes that the drug is given as an injection and may have side effects such as infections and allergic reactions. The article also mentions that Cosentyx may not be suitable for everyone, and that patients should talk to their healthcare provider to determine if it is the right treatment option for them.

In conclusion, while there is no specific information about whether or not Cosentyx is recommended for people with similar symptoms, the drug has been shown to be effective in treating certain autoimmune diseases. Patients should talk to their healthcare provider to determine if Cosentyx is the right treatment option for them. It is also important to note that the drug may have side effects and that patients should continue to take precautions during the COVID-19 pandemic.

Sources:
[1] https://www.drugpatentwatch.com/p/biologics/tradename/COSENTYX
[2] https://www.cosentyx.com/covid19
[3] https://www.medicalnewstoday.com/articles/326632